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Teasaponin improves leptin sensitivity in the prefrontal cortex of obese mice 
Abstract 
Scope Obesity impairs cognition, and the leptin-induced increase of brain-derived neurotrophic factor 
(BDNF) and neurogenesis. Tea consumption improves cognition and increases brain activation in the 
prefrontal cortex. Methods and results This study examined whether teasaponin, an active ingredient in 
tea, could improve memory and central leptin effects on neurogenesis in the prefrontal cortex of obese 
mice, and in vitro in cultured prefrontal cortical neurons. Teasaponin (10 mg/kg, intraperitoneal) for 21 
days improved downstream leptin signaling (JAK2 and STAT3), and leptin's effect on BDNF, in the 
prefrontal cortex of high-fat diet (HFD) fed mice. Prefrontal cortical neurons were cultured with 
teasaponin and palmitic acid (the most abundant dietary saturated fatty acid) to examine their effects on 
neurogenesis and BDNF expression in response to leptin. Palmitic acid decreased leptin's effect on 
neurite outgrowth, postsynaptic density protein 95, and BDNF expression in cultured cortical neurons, 
which was reversed by teasaponin. Conclusion Teasaponin improved the leptin sensitivity of prefrontal 
cortical neurons in obese mice or when treated by palmitic acid. This in turn increased BDNF expression 
and neurite growth. Therefore, teasaponin supplementation may be used to prevent obesity-associated 
neurodegeneration and improve cognitive function. 
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Scope: Obesity impairs cognition, and the leptin-induced increase of brain-derived neurotrophic 
factor (BDNF) and neurogenesis. Tea consumption improves cognition and increases brain 
activation in the prefrontal cortex.  
Methods and results: This study examined whether teasaponin, an active ingredient in tea, 
could improve memory and central leptin effects on neurogenesis in the prefrontal cortex of 
obese mice, and in vitro in cultured prefrontal cortical neurons. Teasaponin (10mg/kg, 
intraperitoneal) for 21 days improved downstream leptin signaling (JAK2, and STAT3), and 
leptin’s effect on BDNF, in the prefrontal cortex of HFD fed mice. Prefrontal cortical neurons 
were cultured with teasaponin and palmitic acid (the most abundant dietary saturated fatty acid) 
to examine their effects on neurogenesis and BDNF expression in response to leptin. Palmitic 
acid decreased leptin’s effect on neurite outgrowth, post-synaptic density protein 95 and BDNF 
expression in cultured cortical neurons, which was reversed by teasaponin.  
Conclusion: Teasaponin improved the leptin sensitivity of prefrontal cortical neurons in obese 
mice or when treated by palmitic acid. This in turn increased BDNF expression and neurite 
growth. Therefore, teasaponin supplementation may be used to prevent obesity-associated 
neurodegeneration and improve cognitive function.  







Recent epidemiological studies have demonstrated that obesity increases the incidence of 
cognitive decline in neurodegenerative diseases, such as vascular dementia [1, 2]. Empirical 
evidence has linked high-fat diet (HFD)-induced obesity with impairments in learning and 
memory, including a decline in recognition memory [3-5]. For example, HFD for 8 weeks 
impairs spatial learning in the eight-arm radial maze test, prior to metabolic alterations linked to 
obesity developing and without significant changes in plasma glucose and insulin levels [4]. 
HFD treatment of juvenile rodents impairs long-term spatial reference memory in the Morris 
water maze, without affecting acquisition or short-term memory [5]. Furthermore, in our 
previous study, recognition memory was impaired in chronic HFD fed mice as assessed by 
performing a novel object recognition test [3]. The prefrontal cortex plays an important role in 
higher cognitive function [6]. Abnormal structure and dysfunction in the prefrontal cortex is 
associated with cognitive decline and the pathogenesis of mood disorders [7-9]. Furthermore, 
positron emission tomography has shown that obese women have reduced activation in the 
prefrontal cortex in response to a meal than lean women [10]. In preclinical animal studies, a 
high-fat diet reduces synaptic plasticity in the prefrontal cortex [11], which leads to learning and 
memory impairments [12]. Moreover, obese patients are leptin resistant and have significantly 
higher levels of plasma leptin, which correlates with body fat mass [13]. Our previous study 
showed that in rodents a high saturated fat diet induces body weight gain followed by the 
development of obesity, which is accompanied by peripheral and then brain leptin resistance 
[14]. Despite this, therapeutic interventions targeting HFD-induced cognitive impairment and 





The adipocyte-secreted hormone leptin has important effects on synaptogenesis and dendritic 
morphology in the brain, which regulate energy homeostasis and facilitate learning and memory 
[15-17]. For example, in vitro, leptin increases neurite outgrowth marker and synaptogenesis 
markers in mouse H19-7 HN neural cell lines, as well as stimulating hippocampal neurogenesis 
by increasing cell proliferation and differentiation [18]. Leptin replacement at physiological 
doses for two years substantially increased the rate of development in most neurocognitive 
domains in dividual with leptin gene mutation [19]. Brain-derived neurotrophic factor (BDNF) 
plays an important role in synaptic plasticity and neurogenesis [20, 21], cognitive function [22] 
and energy metabolism [23] through the activation of its receptor, tropomyosin-related kinase B 
(TrkB). BDNF is broadly expressed in the developing and adult mammalian brain, particularly in 
the cerebral cortex, hippocampus, hypothalamus and brainstem [21]. Plasma BDNF levels are 
positively correlated to memory performance in female patients with major depressive disorder 
[22]. Leptin administration significantly increases hippocampal BDNF in control but not HFD-
induced obese mice suggesting decreased central leptin sensitivity in obese mice. [15]. 
Altogether, this evidence suggests that leptin activation of BDNF in the central nervous system 
may be involved in cognition, while brain leptin resistance could contribute to obesity related 
cognitive decline. 
 
Evidence from clinical and animal studies show that tea has anti-obesity effects [24, 25] and 
improves cognitive function [26, 27]. Treatment with 1 % tea extract in diet for 6 weeks 
decreased body weight and adipose mass in genetically obese (ob/ob) mice [24]. Increased 
consumption of green tea was associated with a lower prevalence of cognitive impairment in a 
cross-sectional study in 1003 Japanese [26], and longitudinal analysis of data from 1438 Chinese 




Phenolics in tea have been widely investigated in previous studies, while teasaponin has received 
little attention. Chemically teasaponin belongs to the oleanane-type pentacyclic triterpene 
saponins, whose amphiphilic nature enables them to intercalate into the cell membrane and 
interact with cell membrane molecules to regulate downstream signaling cascades [28, 29]. Our 
previous study found that teasaponin significantly improves impaired leptin signaling in the 
hypothalamus of HFD fed mice, but did not elicit malaise [30]. In the current study, we 
expanded these findings to investigate the effect of teasaponin on recognition memory and leptin 
signaling in the prefrontal cortex of HFD fed mice. We further investigated the effect of 
teasaponin in cultured primary prefrontal cortical neurons in response to leptin and the saturated 
fatty acid, palmitic acid. 
 
2 Materials and methods 
2.1 Animals. C57Bl/6J male mice (10 weeks old, body weight: 19.6 ± 1.4 g) were obtained from 
the Animal Resources Centre (Perth, Western Australia), and housed in environmentally 
controlled conditions (temperature 22 °C, 12 hour light/dark cycle). Lab chow (LC) served as the 
low-fat control diet (5% fat, Vella Stock Feeds, Doonside, NSW, Australia) and was provided ad 
libitum except where noted. Mice were acclimatised for one week prior to experimentation. All 
procedures were approved by the Animal Ethics Committee, University of Wollongong, NSW, 
Australia, and complied with the Australian Code of Practice for the Care and Use of Animals 
for Scientific Purposes. 
 
2.2 Intraperitoneal (ip) teasaponin treatment. Mice were placed on the HFD (containing 60% 




randomised into two groups, and administered either teasaponin (10 mg/kg) or vehicle (saline) 
i.p. injections daily for 21 days. Age-matched, LC diet control mice were maintained on the lab 
chow diet. Body weight and food intake were measured every two days. Teasaponin (96%, 
C57H90O26, MW=1200) was purchased from the Aladdin Chemistry Co. Ltd, China. 
 
2.3 Intraperitoneal glucose tolerance test (IPGTT). On day 18 of the teasaponin treatment, the 
mice were fasted overnight and given an ip injection of glucose (0.5g/kg) as reported previously 
[31-33]. Blood samples were taken from the tail vein and blood glucose measured using a 
glucometer (Abbott Diabetes Care, Alameda, CA) at 0 (fasting), 30, 60 and 120 min after 
glucose administration. 
 
2.4 Central leptin sensitivity test. After intraperitoneal teasaponin treatment for 21 days, mice 
were anaesthetised and placed in a stereotactic device. A intracerebroventricular (icv) cannula 
was implanted into the right lateral brain ventricle (0.25 mm posterior and 1.0 mm lateral relative 
to Bregma and 2.5 mm below the surface of the skull) [34]. Five days after implantation, mice 
were fasted for 6 hours and administered either leptin (0.1 µg/3 µl) or saline (3 µl) injected into 
the lateral ventricle through the cannula. Food intake and body weight were measured 24 hours 
after the leptin or vehicle injection to examine central leptin sensitivity.  
 
2.5 Blood and tissue collection. Four days after the first central leptin sensitivity test, the mice 
received a second icv leptin or saline injection and were sacrificed one hour later. Plasma and 





2.6 Measurement of plasma leptin and insulin. Plasma leptin and insulin were measured using 
the mouse metabolic magnetic bead panel kit (Merck Millipore, MA, USA). 
 
2.7 Western blot analysis. Protein expression in frozen prefrontal cortex (equivalent to the 
prelimbic cortex, PrL, dissected at the level of Bregma 2.8 mm to 1.98 mm) was determined 
using western blot as described in our previous study [30]. The following antibodies were used: 
BDNF, TrkB 145 and 95, pJAK2 and pAkt (Santa Cruz, CA, USA); pTrkB 95 (Sigma-Aldrich, 
St Louis, MO, USA); and pSTAT3, pGSK3β and pFOXO1 (Cell Signaling Technology, Beverly, 
MA, USA). Bands corresponding to the proteins of interest were scanned and band density 
analysed using the Quantity One automatic imaging analysis system (Bio-Rad Laboratories, 
Hercules, CA, USA). All quantitative analyses were normalised to β-actin, based on our previous 
studies [30]. Due to the small amount of tissue in the prefrontal cortex, we used a previously 
described modified multi-strip western blot [30, 35]. 
 
2.8 Oral teasaponin treatment. Mice were placed on a HFD  for 8 weeks. The animals were then 
randomised into two groups, continuation of HFD for 6 weeks, or HFD with 0.5% teasaponin for 
6 weeks. Age-matched, LC diet control mice were maintained on the lab chow diet. A novel 
object recognition test (detailed in 2.9) was performed 5 weeks after commencing teasaponin 
treatment. Three days after the novel object recognition test, an IPGTT test was performed as 
described in procedure in 2.3. 
 
2.9 The novel object recognition test. This test is based on the innate tendency of rodents to 




modifications. In brief, the experimental procedure consisted of habituation, training and 
retention sessions. On day 1, for habituation, mice were placed into an open-field box (55×55cm 
× 35cm high) for 10 minutes with a 40 W light bulb in a sound proof room. On day 2, during the 
training session, two identical objects (A) were placed at opposing corners of the box, 5cm from 
the adjacent wall. Each mouse was then placed in the middle of the open-field box and left to 
explore the objects for 10 minutes. Ninety minutes later, in the retention session, one familiar 
object (A) was replaced with one novel object (B). Each mouse was placed in the middle of the 
open-field box, and left to explore for another 10 minutes. The exploration time for the familiar 
and the new objects was recorded. Memory was operationally defined by the discrimination 
index for the novel object (DI) as the proportion of time animals spent investigating the novel 
object minus the proportion spent investigating the familiar one in the testing period in the 
retention session [Discrimination Index = (Novel Object Exploration Time/Total Exploration 
Time)–(Familiar Object Exploration Time/Total Exploration Time)×100].  
 
2.10 Prefrontal cortical neuronal cultures and treatment. Prefrontal cortical neuronal cultures 
were prepared from postnatal day 1 mice as described previously [37]. Cells were plated at a 
final density of 5 × 105/cm2 into Poly-D-Lysine-coated 24-well culture plates for RT-PCR 
analysis. For neurogenesis imaging, cortical neurons were cultured on Poly-D-Lysine-coated 
coverslips. At 7 days in vitro, teasaponin and/or palmitic acid (P5585, Sigma-Aldrich) were 
added to the cultures. The method for dissolving palmitic acid was as described by Ross et al 
[38]. Leptin (100 ng/ml) was applied to the neuron cultures for 4 hours, followed by 44 hour 





2.11 Immunofluorescence and image analysis. For immunocytochemical staining, neurons were 
fixed with 4% paraformaldehyde and 4% sucrose in Dulbecco's PBS for 20 min at room 
temperature. The samples were incubated with PBS containing 0.2% Triton X-100 for 5 min, and 
blocked with 10% horse serum in PBS for 1 h at 37 °C. Then, either anti-BDNF antibody, anti-
microtubule-associated protein 2 (MAP2) antibody, anti-synaptophysin (SYN) antibody, and 
anti-post-synaptic density protein 95 (PSD 95) antibody were applied overnight at 4 °C. MAP2 
was visualised by goat anti-mouse IgG (H+L) secondary antibody conjugated to Alexa Fluor 
594. BDNF, SYN and PSD95 were visualised with isotype-specific donkey anti-rabbit IgG 
(H+L) secondary antibody conjugated with Alexa Fluor 488. The origin and concentration of 
antibodies were given in the Table S1 for details. A fluorescent microscope (Axiovert 200, Carl 
Zeiss, Oberkochen, Germany) and digital camera were used to obtain images.  
 
2.12 Neurite outgrowth and branching analysis. An open source toolkit “NeuriteQuant V1.23” 
(http://www.ccb.tu-dortmund.de/groups/CB/bastiaens/dehmelt/NeuriteQuant/) was installed as a 
plugin for Image J 1.40g (http://rsbweb.nih.gov/ij/download.html). The image processing 
algorithm for quantification of neuronal morphology by NeuriteQuant has been described 
previously [39].  
 
2.13 Quantitative PCR. Quantitative real-time PCR (qPCR) was performed as previously 
described [30]. The primers used are listed in Table S2. Amplification was carried out with 45 
cycles of 95 °C for 10 seconds, 60 °C for 30 seconds and 72 °C for 30 seconds. The mRNA 
expression levels for BDNF, MAP2, SYN and PSD95 were normalised to γ-actin, which served 





2.14 Statistical analysis. Data were analysed using the SPSS 19 statistical package (SPSS, 
Chicago, IL, USA). One-way analysis of variance (ANOVA) and the post-hoc Tukey-Kramer 
honestly significant difference (HSD) test were used to analyse the novel recognition test, body 
weight, visceral fat, liver weight and the glucose tolerance test and leptin signaling of the LC, 
HFD, and teasaponin treatment groups in response to saline and leptin, as well as data from the 
cell culture experiments. A p value < 0.05 was regarded as statistically significant. Values are 
expressed as meanSEM. 
3 Results 
3.1 Teasaponin prevented weight gain, fat deposition and improved glucose intolerance in 
HFD fed mice.  
Teasaponin treatment (ip injection) significantly reduced body weight gain (Fig 1A). The final 
body weight of the teasaponin treatment group was significantly lower than that of HFD mice, 
but still higher than LC group (Fig B). As shown in Fig 1C, treatment with teasaponin 
significantly decreased average energy intake in HFD fed mice. Teasaponin treatment also 
significantly decreased epididymal fat and liver weight in animals maintained on a HFD diet (Fig 
1D and E). In the IPGTT, blood glucose levels were lower at the 0, 30, 60 and 120 minute time 
points in the teasaponin treatment group compared to the HFD group (Figure 1F). However, 
blood glucose at 60 and 120 minutes in the teasaponin group was still higher than the LC group. 
In addition, we observed similar effects in the prevention of excessive weight gain, food intake 
and fat deposition, enlarged liver weight, and glucose intolerance (Fig. S1A – F), as well as 





3.2 Teasaponin restored leptin-pJAK2-pSTAT3 signaling in the prefrontal cortex of HFD 
fed mice. Several molecules, including JAK2-STAT3 and Akt-FOXO1/GSK, have been 
established as downstream mediators of leptin signaling in the hypothalamus [40-42]. Here we 
examined the leptin signaling pathways JAK2-STAT3 and Akt-FOXO1/GSK in the prefrontal 
cortex. An icv injection of leptin significantly increased pJAK2 in the prefrontal cortex of LC 
mice (p<0.001), but not in HFD fed mice (p>0.05, Fig 2A). However, with teasaponin treatment, 
the leptin injection significantly increased pJAK2 in HFD fed mice compared to saline injection 
(p<0.05). There was a similar response in the pSTAT3, downstream step of leptin/pJAK2 
signaling in the LC, HFD and teasaponin-treated HFD mice (Fig 2B). Leptin significantly 
increased pSTAT3 by 42% in the prefrontal cortex of LC mice, while in HFD fed mice pSTAT3 
only increased by 16% after the leptin injection. Following chronic teasaponin treatment, 
pSTAT3 increased by 46% in response to leptin compared with the saline injection, suggesting 
that teasaponin improved leptin-pJAK2-pSTAT3 signaling in HFD fed mice. We also found that 
leptin significantly increased pAkt, pGSK3β and pFOXO1 in the prefrontal cortex of LC but not 
in HFD fed mice (p<0.05, Fig 2C-E). However, teasaponin treatment did not reverse impaired 
leptin-pAkt-pGSK3β/pFOXO1 signaling in HFD fed mice. After icv leptin injection, the BDNF 
level in the prefrontal cortex was significantly increased in LC mice (p<0.05), but not in HFD 
fed mice (Fig 2F). Importantly, with chronic teasaponin treatment, leptin increased BDNF levels 
compared to saline in the prefrontal cortex of HFD fed mice, suggesting that teasaponin 
treatment improved the leptin-induced increase in BDNF in the prefrontal cortex. However, 





3.3 Teasaponin restored central leptin sensitivity, and improved hyperinsulinemia and 
hyperleptinemia in HFD fed mice. In the LC group, there was a significant decrease in energy 
intake and body weight gain 24 hours after icv leptin (p<0.05, Table 1). However, in the HFD 
group leptin did not significantly decrease 24 hour energy intake and body weight gain, 
indicating decreased central leptin sensitivity. Teasaponin treatment restored central leptin 
sensitivity in the HFD group, as leptin injections decreased energy intake and body weight gain 
compared with saline in teasaponin treated HFD fed mice (p<0.05). A significant reduction in 
plasma insulin levels (-38.9%, p<0.05) was also observed in response to the icv leptin in LC 
mice, but not in HFD fed mice (-28.2%, p>0.05). Teasaponin treatment significantly decreased 
hyperinsulinemia in HFD fed mice by decreasing baseline circulating insulin by 56.2% (p<0.05), 
while leptin injection did not further decrease plasma insulin in the teasaponin treatment group. 
teasaponin treatment significantly attenuated hyperleptinemia in HFD fed mice (p<0.05). 
 
3.4 Palmitic acid decreased leptin-induced BDNF production which can be corrected by 
teasaponin in the cortical neurons. In cultured prefrontal cortical neurons, immunostaining 
with anti-BDNF antibody showed a granular distribution of BDNF in MAP2-positive neurons 
(Fig 3B). Leptin treatment significantly increased BNDF immunoreactivity by 64% (p<0.001, 
Fig 3A) and mRNA expression 2.5 fold (p<0.05, Fig 3D). However, following palmitic acid pre-
treatment, leptin did not increase BDNF immunoreactivity or mRNA expression (Figs 3A and 
3D). This suggests that palmitic acid inhibits leptin stimulation of BDNF in prefrontal cortex 
neurons. Importantly, for both the low and high doses of teasaponin treatment, leptin 
significantly increased BDNF immunoreactivity in cortical neurons (both p<0.001), even when 




(20 µM) dose teasaponin, increased basal BDNF immunoreactivity (Fig 3A and 3C). Teasaponin 
(40 µM) also induced a significant increase in BDNF mRNA (p<0.05), suggesting that the 
teasaponin-induced increase in BDNF is due to an increase in BDNF translation.  
 
3.5 Teasaponin promoted neurite outgrowth in response to leptin in cultured prefrontal 
cortical neurons. We examined the effect of teasaponin on neurite outgrowth in cells treated 
with leptin and palmitic acid (Figs 4A and 4B). Morphological analyses showed that leptin 
significantly increased the average neurite length (Fig. 4D) and total neurite length per cell (Fig. 
4E) in control cortical neurons, but not in palmitic acid treated neurons. Whereas with teasaponin 
pre-treatment, leptin increased average neurite length (45%, p<0.05, Fig. 4D) and total neurite 
length per cell (45%, p<0.05, Fig. 4E) compare to saline, suggesting teasaponin attenuated the 
effect of palmitic acid on leptin-induced neurite length. However, the neurite number per cell in 
cortical neurons was not affected by leptin, PA or teasaponin (Fig. 4F). Furthermore, leptin 
treatment significantly increased neurite branching (branches per neurite: +59%, Fig. 4G, 
branches per cell: +59%, Fig. 4H) compared with saline treatment in control neurons, but not in 
palmitic acid treated neurons. With teasaponin pretreatment, leptin significantly increased 
branches per neurite, but not branches per cell. The mRNA expression of MAP2, a neurite 
marker, was also examined by RT-PCR. Teasaponin prevented palmitic acid from inhibiting the 
leptin-induced stimulation of MAP2 mRNA (Fig 4I). 
 
3.6 Teasaponin promoted synaptogenesis in response to leptin in cultured prefrontal 
cortical neurons. Immunofluorescence microscopy showed that both SYN (pre-synaptic 




spine of neurites (Figs 5A and 5C). The RT-PCR results also show that leptin significantly 
increased SYN and PSD95 mRNA expression in cultured cortical neurons (p<0.05, Figs 5B and 
5D). Palmitic acid had no effect on basal SYN and PSD95 mRNA expression. However, it 
significantly inhibited SYN and PSD95 mRNA expression in response to leptin. Teasaponin 
prevented the inhibitory effect of palmitic acid on the leptin-induced stimulation of PSD95 
mRNA expression (p<0.05), but not SYN mRNA expression. 
 
4 Discussion 
Our results show that chronic teasaponin treatment enhanced object recognition memory, and 
improved leptin signaling and leptin-induced BDNF expression in the prefrontal cortex of HFD 
fed mice. Moreover, in cultured primary prefrontal cortical neurons, palmitic acid impaired the 
effect of leptin on BDNF, neurite growth and synaptogenesis markers, and teasaponin 
ameliorated these palmitic acid induced effects. Previously, both clinical and animal studies have 
shown that tea improves cognitive function [26, 27] and prevents impairments of learning and 
memory [43]. Furthermore, tea increases brain activity in the prefrontal cortex of healthy 
volunteers as assessed by functional MRI methods [44]. In the present study, treatment with 
teasaponin, an important active ingredient of tea, enhanced memory for object recognition in 
HFD fed mice. Therefore, the effect of teasaponin on memory may contribute to the ability of tea 
to improve cognitive function and memory, and increase brain activation in the prefrontal cortex, 
as described previously [26, 27, 44].  
 
In the present study, central acute administration of leptin significantly increased its downstream 




with our results, another study demonstrated that systemic administration of leptin activated 
STAT3 phosphorylation in cortical neurons, in a rat model of cerebral ischemia [45]. We also 
have demonstrated that leptin activates pAkt, pFOXO1 and pGSK3β, another leptin signaling 
pathway, in the prefrontal cortex of LC mice. In obesity plasma leptin is increased, which 
theoretically will prevent overeating and obesity. However, this is not the case as leptin 
resistance is a pathology of obesity [46]. Furthermore, obese subjects with hyperleptinemia have 
an increased prevalence of dementia and other neurodegenerative disease [47-49]. Therefore, it is 
unlikely that high plasma leptin levels will appropriately activate signaling pathways in the brain 
of obese individuals with leptin resistance. Indeed, our results showed that, in HFD fed obese 
mice, both the leptin-pJAK2-pSTAT3 and pAkt-pGSK3β/pFOXO1 signaling pathways were 
impaired in the prefrontal cortex. Importantly, teasaponin treatment corrected alteration of the 
leptin-pJAK2-pSTAT3 signaling pathway in the prefrontal cortex of HFD fed mice. It has been 
reported that leptin replacement improves cognition in leptin-deficient patients with a delay or 
decline of cognitive function [19]. The prefrontal cortex is important for cognitive control [6], 
and HFD reduces synaptic plasticity in this region [11] leading to learning and memory 
impairments [12]. Therefore, teasaponin may attenuate HFD induced impairments of leptin 
signaling in the prefrontal cortex, leading to improved recognition memory. 
 
In the prefrontal cortex, BDNF promotes neuronal plasticity and neurogenesis, which are 
important for learning and memory [7, 50]. HFD diet reduced BDNF in the prefrontal cortex and 
impaired discrimination reversal learning in rats [7]. A continuous icv infusion of antisense 
BDNF oligonucleotide resulted in an impairment of spatial learning in rats, with a significant 




BDNF levels in plasma are positively correlated to memory performance in patients with 
depression [22]. Leptin administration has been shown to increase BDNF expression in the 
hippocampus of mice, which can be blocked by pre-treatment with K252a, a blocker of the 
BDNF receptor [15]. In this study, we observed that leptin stimulated BDNF expression in the 
prefrontal cortex of control mice, but not in HFD fed obese mice. In cultured primary prefrontal 
cortical neurons, leptin increased BDNF mRNA expression and immunoreactivity, however, this 
effect was impaired by palmitic acid. Along with improving the leptin-pJAK2-pSTAT3 signaling 
pathway, our results demonstrated a beneficial effect of teasaponin on the upregulation of BDNF 
by leptin. These results suggest that teasaponin-induced activation of leptin signaling may have 
modulated BDNF expression, enhancing neuronal plasticity in the prefrontal cortex and 
contributing to an improvement in recognition memory. 
 
It is known that BDNF-mediated synaptic plasticity is usually coordinated by the synaptogenic 
proteins, SYN and PSD-95 [52-55]. SYN, a presynaptic vesicle phosphoprotein, is a marker of 
presynaptic nerve terminal density which regulates synaptic function, vesicle fusion, and 
neurotransmitter release [56]. PSD-95 is an important regulator of synaptic strength and 
plasticity [57, 58]. It has been reported that the expression of synaptogenesis markers, SYN and 
PSD95 depends on BDNF processing [59, 60]. Consistent with this, along with increased BDNF 
levels, our findings demonstrated that leptin stimulated SYN and PSD95 mRNA expression in 
vitro. Furthermore, mRNA expression of the neurite outgrowth marker MAP2 increased in 
response to leptin in cultured prefrontal cortical neurons. It is well established that leptin has 
important effects on neurogenesis, synaptogenesis and dendritic morphology in the brain [15, 




via increasing BDNF, SYN and PSD95 in cortical neurons. It has been reported that a diet high 
in saturated fatty acids induces neuronal degeneration and inactivates the leptin signaling 
molecule STAT3 in the hypothalamus of mice [62]. We observed that the neurite outgrowth and 
synaptogenesis responses to leptin were impaired in the cultured primary prefrontal cortical 
neurons pre-treated with palmitic acid. This suggests that saturated fatty acids also induce a 
leptin insensitivity effect on neurite outgrowth and synaptogenesis in the prefrontal cortical 
neurons. We also found that teasaponin reversed this adverse effect of palmitic acid on leptin-
induced BDNF, neurite outgrowth and post-synaptogenic protein PSD95. It is known that the 
leptin signaling molecules, JAK2 and STAT3, are distributed around the postsynaptic sites in the 
cerebral cortex [63]. This suggests that teasaponin may modulate leptin signaling, BDNF 
expression and post-synaptic function in the prefrontal cortex, leading to improved recognition 
memory.  
 
Teasaponin belongs to a family of molecules named steroidal saponins or triterpene saponins 
[64]. Steroidal saponins have an amphiphilic nature and are able to intercalate into the plasma 
membrane, replacing membrane cholesterol and increasing membrane fluidity. Thus, this 
molecule could change the immediate environment of cell membrane proteins, such as the 
GABA receptor [28, 29]. However, it remains to be determined if teasaponin directly interacts 
with the leptin receptor. This study demonstrated that teasaponin increased leptin sensitivity in 
the prefrontal cortex of obese mice, and in prefrontal neurons treated with PA, as well as 
reversed the alterations of leptin downstream signaling molecules (pJAK2, STAT3, BDNF and 
PSD95) (Fig S2). Furthermore, it is reported that hyperleptinemia is required for the 




significantly attenuates hyperleptinemia in HFD fed mice, which may reduce the overstimulation 
of the leptin receptor, thereby improving downstream signaling.  
 
In summary, the findings of our study demonstrate that teasaponin improves recognition memory 
in the HFD fed mice. Through in vivo and in vitro studies we revealed that leptin activated 
leptin-pJAK2-pSTAT3 and pAkt-pFOXO1/pGSK3β signaling and stimulated BDNF expression 
and in the prefrontal cortex. However, these prefrontal cortex responses are impaired when mice 
are fed a high-saturated fat diet, or neurons exposed directly to saturated fatty acid, i.e. palmitic 
acid in vitro. Teasaponin treatment ameliorates alteration of leptin-pJAK2-pSTAT3 and leptin-
BDNF in the prefrontal cortex of HFD fed mice and improves hyperleptinemia. Treatment with 
teasaponin also promoted leptin’s effect on neurite outgrowth and synaptogenesis in prefrontal 
cortical neurons. Since high fat diet-induced obesity has been implicated in the progression of 
neurodegenerative diseases, such as vascular dementia, teasaponin supplementation may have 
beneficial effects in attenuating the progression of cognitive decline in obese patients and 
reducing the risk of neurodegenerative diseases. The dose of teasaponin obtained by frequently 
drinking tea is significantly lower than the doses used in this rodent study. In order to reach the 
effect observed in this study, a supplemental delivery of teasaponin (oral or injection) would be 
needed. Clinical trials would also be required to determine the optimum dose in humans. 
Furthermore, the potential toxicity of long-term teasaponin exposure should be investigated 
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Table 1. Central leptin sensitivity and plasma levels of leptin and insulin in experiment groups in response to 
icv leptin injection 
 
LC group HFD group 
 
HFD+TS group    
 saline leptin saline leptin  saline leptin 
Central leptin sensitivity    
EI (kcal/24 h) 15.65±1.12 10.01±1.06a  18.99±1.10 14.55±1.41  15.48±1.01b 10.35±1.22bc
BWC (g/24 h) -0.19±0.084 -1.05±0.13a  -0.13±0.12 -0.65±0.25  -0.19±0.09 -1.90±0.37 bcd
   
Insulin (ng/ml) 1.31±0.11 0.80±0.10a  3.61±0.59a 2.59±0.37  1.58±0.39b 1.29±0.12b
Leptin (ng/ml) 0.65±0.08 0.79±0.09  16.78±2.02a 14.14±2.41  2.52±0.33bc 4.55±0.59bc
Central leptin sensitivity: Energy intake (EI) and body weight change (BWC) for 24 hours after icv leptin injection. 
LC: lab chow diet fed mice, HFD: high-fat diet fed mice; HFD+TS: HFD fed mice with teasaponin treatment (TS). 
ap<0.05 vs LC/saline; bp<0.05 vs HFD/saline; cp<0.05 vs HFD/leptin; dp<0.05 vs. HFD/TS/saline. Data are presented 


















Fig 1. Teasaponin treatment (TS, 10mg/kg, ip for 21 days) significantly improved metabolic parameters in mice fed high-fat diet (HFD) for 16 
wks. Teasaponin reduced body weight gain (A), final body weight (B) average energy intake (C), epididymal fat (D) and liver weight (E) and 
glucose intolerance (F) in mice fed HFD for 16 wks. * p<0.05 vs. LC fed mice. # p<0.05 vs. HFD fed mice. Data are presented as mean±SEM, 









Fig 2. Effect of teasaponin treatment (TS, 10mg/kg, ip for 21 days) on leptin-pJAK2-pSTAT3 signaling (A, B), pAkt-pGSK3β/pFOXO1 (C-E) 
and leptin-BDNF in the prefrontal cortex of high-fat diet (HFD) fed mice. *p<0.05 vs. saline in individual group. Data are presented as 





Fig 3. Palmitic acid (PA) decreased leptin-
induced BDNF immunoreactivity (A, C) and 
mRNA expression (D) in cultured prefrontal 
cortical neurons, which can be corrected by 
teasaponin (TS). A and C: High dose of TS 
and leptin significantly increased BDNF 
immunoreactivity in cortical neurons. Pre-
treatment with PA significantly inhibited 
leptin-induced BDNF. Both low and high 
dose of TS prevented PA from inhibiting the 
leptin-induced stimulation of BDNF. C: RT-
PCR analysis of BDNF mRNA expression. 
B: Immunocytochemistry images showing 
the typical BDNF-containing vesicles 
(indicated by white arrowheads), taken by 
Confocal Microscope (Nikon).  
For quantification of BDNF 
immunoreactivity, the mean intensity of 
BDNF fluorescence in 2–3 areas of the cell 
body per cell (approximately 100 μm2) was 
measured using the software Image J 1.46r 
(http://rsbweb.nih.gov/ij/download.html). 
Fifteen randomly selected neurons were 
analysed at ×100 magnification. Data 
expressed as mean±SEM (n=6, obtained 
from 6 independent culture wells). *p<0.05. 
Leptin (100 ng/ml) was applied to the neuron 
cultures 4 hours after 44 hour exposure to TS 
(20 or 40µM) or palmitic acid (10 µM). 







Fig 4. Effect of teasaponin (TS) and palmitic acid (PA) on the leptin-induced neurite outgrowth. A: represents fluorescence images obtained 
under Confocal Microscope (Nikon), scale bar = 50 μm; B: an example of MAP2 immunofluorescence staining image (8 bit) used for neuron 
morphology analysis, scale bar = 100 μm; C: an example of analysis tracing of neuron morphology quantification by using NeuriteQuant toolkit. 
All parameters (D-H) used were automatically analysed and calculated by the algorithm of NeuriteQuant in pixels, n=9; D: Average neurite 
length; E: Neurite length per cell; F: Neurite number per cell; G: Branches per neurite; H: Branches per cell; I: MAP2 mRNA expression 
measured by qRT-PCR (n=5-7). *p<0.05 vs. saline in individual group. Data are presented as mean ± SEM. Leptin (100 ng/ml) was applied to 







Fig 5. Effect of teasaponin (TS) and palmitic acid (PA) on the leptin-induced synaptogenesis markers, SYN (A and B) and PSD95 (C and D), in 
cultured primary prefrontal cortical neurons. A and C represent fluorescence images obtained under Confocal Microscope (Nikon). B and D 
represent RT-PCR analysis of SYN and PSD95 mRNA expression. *p<0.05 vs. saline in individual group. Data are presented as mean±SEM, 
n=5–6. Cultured primary prefrontal cortical neurons were pre-treated with teasaponin (40 µM) for 5 hours and PA (10 µM) for 4 hours and then 
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Table S1. The antibodies used in this study 
Peptide/protein 
target 
Name of Antibody Manufacturer, catalog # 
Species raised in 
monoclonal or polyclonal 
Dilution 
used 
BDNF BDNF (H-117) Santa Cruz Biotechnology, sc-20981 Rabbit, Polyclonal 1:400 
TrkB 145 and 95 TrkB (H-181) Santa Cruz Biotechnology, sc-8316 Rabbit, Polyclonal 1:500 
pTrkB 95 Anti-phospho-Trk B 
(pTyr705) 
Sigma-Aldrich, SAB4503786 Rabbit, Polyclonal 1:500 
p-JAK2 p-JAK2 (Tyr 1007/Tyr 1008) Santa Cruz Biotechnology, sc-21870 Goat, Polyclonal 1:500 
p-STAT3 
Phospho-Stat3 (Tyr705) 
(D3A7) XP® Rabbit mAb 
Cell Signaling Technology, #9145 Rabbit, Monoclonal 1:2000 
pAkt p-Akt1/2/3 (Ser 473)-R Santa Cruz Biotechnology, sc-7985-R Rabbit, Polyclonal 1:500 
pGSK3β 
Phospho-GSK-3β 
(Ser9)(5B3) Rabbit mAb 
Cell Signaling Technology, #9323 Rabbit, Monoclonal 1:1000 




Sigma-Aldrich, #M4403 Mouse, Monoclonal  1:500 
SYN Anti-Synaptophysin antibody Sigma-Aldrich, SAB4502906 Rabbit, Polyclonal 1:100 




Table S2. The primers used in qPCR for mRNA measurement of neurogenesis markers  
GENE Forward primer Reverse primer NCBI reference
BDNF GGGTCACAGCGGCAGATAAA GCCTTTGGATACCGGGACTT NM_001285416.1 
MAP2 ATGAAGGAAAGGCACCACAC AATAGGTGCCCTGTGACCTG NM_001039934.1 
SYN GAACAAGTACCGAGAGAACAACAA GGTCAGTGGCCATCTTCACA NM_009305.2 
PSD95 GGTGACGACCCATCCATCTTTATC CGGACATCCACTTCATTGACAAAC NM_007864.3 






Fig S1. Teasaponin treatment (TS, 0.5% in high-fat diet for 6 weeks) significantly improved 
metabolic parameters and recognition memory deficits  in mice fed high-fat diet (HFD) for 8 
wks. Teasaponin prevented body weight gain (A), final body weight (B), average energy 
intake (C), epididymal fat (D) and liver weight (E) and glucose intolerance (F) in mice fed 
HFD for 8 wks. (G) Teasaponin attenuated HFD-induced decline in discrimination index 
reflecting recognition memory in the novel object recognition test in mice. Discrimination 
Index = (Novel Object Exploration Time / Total Exploration Time) – (Familiar Object 
Exploration Time / Total Exploration Time) × 100. * p<0.05 vs. LC fed mice. # p<0.05 vs. 





























































































































































Fig S2. Teasaponin improves leptin sensitivity 
through actions on leptin-JAK2/STAT3, BDNF and 
PSD95 molecules in the prefrontal cortex. HFD: 
high-fat diet; PA: palmitic acid. 
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